Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2 Trial Evaluating the Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease
NCT07804381 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2 Trial Evaluating the Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease
- Lead sponsor
- Yonsei University
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- December 15, 2026
- Completion date
- April 1, 2029
- Enrollment
- 160 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.